All the Active Ingredient Drugs
Recombinant Human Erythropoietin. Recombinant-human Erythropoietin 2,000 U/0.5ml, 3,000 U/0.3ml, 4,000 U/0.4ml, 5,000 U/0.5ml, 6,000 U/0.6ml, 8,000 U/0.8ml, 10,000 U/ml, 20,000 U/0.5ml, 30,000 U/0.75ml, 40,000 U/ml. PREFILL. SYRINGES: 2,000 U/0.5 ml, 3,000 U/0.3 ml, 4,000 U/0.4 ml, 5,000 U/0.5 ml, 6,000 U/0.6 ml, 8,000 U/0.8 ml. 10,000 U/ml, 20,000 U/0.5 ml, 30,000 U/0.75 ml, 40,000 U/ml. For I.V. or S.C. admin. See lit.
Severe anem. assoc. with chron. renal fail; zidovudine treated HIV infect. pts; cancer pts. on chemother.; autolog. blood predonat.; perisurgery.
C/I: Hypersens.
Pts. who develop pure red cell aplas. (PRCA) follow. tmt. with any erythropoietin should not receive EPREX or any other erythropoietin.
Uncontrol. hypertens.
All contraindications assoc. with autologous blood predonation program. should be respect. in pts. being supplem. with epoetin alfa.
The use of epoetin alfa in pts. scheduled for major elect. orthopaedic surg. and not participat. in an autologous blood predonation program. is contraindic. in pts. with severe coronary, peripher. arterial, carotid or cerebr. vasc. dis., includ. pts. with recent MI or cerebral vasc. accident.
Surg. פts. who for any reason cannot receive adequate antithrombot. prophylax.
